Abstract MP262: Endogenous Smad7 Restrains Myofibroblast Activation And Protects From Post-infarction Heart Failure By Suppressing Tgf-beta Signaling And By Directly Inhibiting Erbb2Claudio Humeres, Nikolaos G. Frangogiannis, Simon Conway et al.|Circulation Research|2021Cited by 0